Jeng-Horng Her
Inventor
Stats
- 8 US patents issued
- 23 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 8 US Patents Issued
- 23 US Applications Filed
- 213 Total Citation Count
- Jul 17, 2023 Most Recent Filing
- Jan 16, 2001 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
Multispan, Inc. | 2
1 1 | 2006
2010 2012 |
INNOVENT BIOLOGICS, INC. | 1
| 2012
|
KALOBIOS, INC. | 1
3 1 1 | 2001
2002 2003 2004 |
HORIZON BIOTECHNOLOGIES, INC. | 1
| 2001
|
AP BIOSCIENCES, INC. | 1
1 | 2012
2016 |
ALLGENESIS BIOTHERAPEUTICS INC. | 1
| 2016
|
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2
| 2002
|
HUMANIGEN, INC. | 2
| 2005
|
KALOBIOS PHARMACEUTICALS, INC. | 2
1 2 | 2001
2002 2003 |
Inventor Addresses
Address | Duration |
---|---|
San Jose, CA | Oct 24, 02 - Oct 07, 08 |
San Jose, CA, US | Jun 09, 09 - Jan 23, 25 |
Sunnyvale, CA, US | Mar 19, 15 - Jun 05, 18 |
Taipei City, TW | Dec 28, 17 - Dec 28, 17 |
Taipei, TW | Apr 12, 22 - Apr 12, 22 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 11 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 7 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 2 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0026,841 | 2025 | BISPECIFIC ANTIBODIES TARGETING CD137 AND USES THEREOF FOR ANTI-CANCER IMMUNOTHERAPY | 0 |
2024/0400,717 | 2024 | Antibody Binding to CHI3L1 for Treating Cancer | 0 |
2024/0391,976 | 2024 | Bi-Functional Fusion Proteins to Complement Pathways and Method of Inhibiting Bone Resorption | 0 |
2024/0026,018 | 2024 | ANTIBODIES FOR T-CELL ACTIVATION | 0 |
2023/0322,939 | 2023 | PD-L1 AND OX40 BINDING PROTEINS FOR CANCER REGULATION | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.